ST7L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.267400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.961800E-01
Normal-vs-Stage2
2.318400E-01
Normal-vs-Stage3
2.340000E-02
Normal-vs-Stage4
8.949400E-01
Stage1-vs-Stage2
2.415000E-01
Stage1-vs-Stage3
6.128100E-02
Stage1-vs-Stage4
8.666000E-01
Stage2-vs-Stage3
6.220400E-03
Stage2-vs-Stage4
2.285200E-01
Stage3-vs-Stage4
2.312300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.385800E-01
Normal-vs-AfricanAmerican
2.800400E-01
Normal-vs-Asian
5.016000E-01
Caucasian-vs-AfricanAmerican
8.788800E-01
Caucasian-vs-Asian
9.907000E-01
AfricanAmerican-vs-Asian
9.173800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.526780E-01
Normal-vs-Female
5.822000E-01
Male-vs-Female
1.155740E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.162400E-01
Normal-vs-Age(41-60Yrs)
7.051200E-01
Normal-vs-Age(61-80Yrs)
2.154600E-01
Normal-vs-Age(81-100Yrs)
7.517500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.008400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.045400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.855200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.958100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.019700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.089000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.515200E-01
Normal-vs-Daily Drinker
1.630770E-01
Normal-vs-Weekly Drinker
1.715430E-01
Normal-vs-Occasional Drinker
8.065600E-01
Normal-vs-Social Drinker
5.378600E-01
Non Drinker-vs-Daily Drinker
7.511400E-01
Non Drinker-vs-Weekly Drinker
9.988200E-01
Non Drinker-vs-Occasional Drinker
6.569700E-02
Non Drinker-vs-Social Drinker
2.729200E-01
Daily Drinker-vs-Weekly Drinker
7.872800E-01
Daily Drinker-vs-Occasional Drinker
1.456800E-01
Daily Drinker-vs-Social Drinker
4.043800E-01
Weekly Drinker-vs-Occasional Drinker
1.459370E-01
Weekly Drinker-vs-Social Drinker
3.696400E-01
Occasional Drinker-vs-Social Drinker
5.635800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.374000E-01
Normal-vs-Grade 2
8.564200E-01
Normal-vs-Grade 3
9.343400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.780800E-01
Grade 1-vs-Grade 3
6.032200E-01
Grade 1-vs-Grade 4
7.374000E-01
Grade 2-vs-Grade 3
1.947960E-01
Grade 2-vs-Grade 4
8.564200E-01
Grade 3-vs-Grade 4
9.343400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.316190E-01
Normal-vs-NonDiabetic
3.413200E-01
Diabetic-vs-NonDiabetic
2.344800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.752600E-01
Normal-vs-NoPancreatitis
2.867600E-01
Pancreatitis-vs-NoPancreatitis
3.829600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.596400E-01
Normal-vs-N1
2.520600E-01
N0-vs-N1
6.410600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.069600E-01
Normal-vs-TP53-NonMutant
6.985200E-01
TP53-Mutant-vs-TP53-NonMutant
3.210400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
